Merck & Company News - July 16, 2026

Merck Wins FDA Approval for Lipfendra, First Oral Cholesterol-Lowering Pill

The U.S. Food and Drug Administration approved Merck’s Lipfendra (enlicitide) for the treatment of hypercholesterolemia. This once-daily pill represents the...

🟢 Merck is trading 3.2% up today as UnitedHealth earnings lift healthcare sector

Merck is trading 3.2% up at $127.62 as a rally in healthcare stocks, sparked by strong UnitedHealth results, lifts the broader sector. • The XLV healthcare...